View in EDS

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.

Saved in:
Bibliographic Details
Title: The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
Authors: Caswell DR; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. deborah.caswell@crick.ac.uk., Gui P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Mayekar MK; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Law EK; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., Pich O; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Bailey C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Boumelha J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Kerr DL; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Blakely CM; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Manabe T; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Martinez-Ruiz C; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Bakker B; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., De Dios Palomino Villcas J; Core Research Laboratory, ISPRO, Florence, Italy., I Vokes N; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dietzen M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Angelova M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Gini B; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Tamaki W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Allegakoen P; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Wu W; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Humpton TJ; p53 and Metabolism Laboratory, The Francis Crick Institute, London, UK.; CRUK Beatson Institute, Glasgow, UK.; Glasgow Caledonian University, Glasgow, UK., Hill W; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Tomaschko M; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Lu WT; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Haderk F; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Nagano A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Gimeno-Valiente F; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., de Carné Trécesson S; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Vendramin R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Barbè V; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Mugabo M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Weeden CE; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., McCoach CE; Genentech Inc, South San Francisco, CA, USA., Almeida B; The Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK., Green M; Experimental Histopathology, The Francis Crick Institute, London, UK., Gomez C; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Nanjo S; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Barbosa D; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Moore C; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Przewrocka J; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Black JRM; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Grönroos E; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Suarez-Bonnet A; Experimental Histopathology, The Francis Crick Institute, London, UK.; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK., Priestnall SL; Experimental Histopathology, The Francis Crick Institute, London, UK.; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK., Zverev C; Biological Research Facility, The Francis Crick Institute, London, UK., Lighterness S; Biological Research Facility, The Francis Crick Institute, London, UK., Cormack J; Biological Research Facility, The Francis Crick Institute, London, UK., Olivas V; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Cech L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Andrews T; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Rule B; Cursorless, London, UK., Jiao Y; Novogene Europe, Cambridge, UK., Zhang X; Novogene Europe, Cambridge, UK., Ashford P; Institute of Structural and Molecular Biology, University College London, London, UK., Durfee C; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA., Venkatesan S; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Temiz NA; Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Tan L; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Larson LK; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., Argyris PP; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.; School of Dentistry, University of Minnesota, Minneapolis, MN, USA.; College of Dentistry, Ohio State University, Columbus, OH, USA., Brown WL; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA., Yu EA; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Sutter Health Palo Alto Medical Foundation, Department of Pulmonary and Critical Care, Mountain View, CA, USA., Rotow JK; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Guha U; Thoracic and GI Malignancies Branch, NCI, NIH, Bethesda, MD, USA.; NextCure Inc., Beltsville, MD, USA., Roper N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yu J; Biomedical Sciences Program, University of California, San Francisco, San Francisco, CA, USA., Vogel RI; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA., Thomas NJ; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA., Marra A; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy., Selenica P; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Yu H; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell College of Medicine, New York City, NY, USA., Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Chew SK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK., Reis-Filho JS; Memorial Sloan Kettering Cancer Center, New York City, NY, USA., Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK., Vousden KH; p53 and Metabolism Laboratory, The Francis Crick Institute, London, UK., McGranahan N; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kanu N; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK., Harris RS; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Downward J; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK., Bivona TG; Departments of Medicine and Cellular and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Chan Zuckerberg Biohub, San Francisco, CA, USA. trever.bivona@ucsf.edu., Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
Source: Nature genetics [Nat Genet] 2024 Jan; Vol. 56 (1), pp. 60-73. Date of Electronic Publication: 2023 Dec 04.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38049664
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Caswell+DR%22">Caswell DR</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. deborah.caswell@crick.ac.uk.<br /><searchLink fieldCode="AU" term="%22Gui+P%22">Gui P</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Mayekar+MK%22">Mayekar MK</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Law+EK%22">Law EK</searchLink>; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Pich+O%22">Pich O</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Bailey+C%22">Bailey C</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Boumelha+J%22">Boumelha J</searchLink>; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Kerr+DL%22">Kerr DL</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Blakely+CM%22">Blakely CM</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Manabe+T%22">Manabe T</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Martinez-Ruiz+C%22">Martinez-Ruiz C</searchLink>; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Bakker+B%22">Bakker B</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22De+Dios+Palomino+Villcas+J%22">De Dios Palomino Villcas J</searchLink>; Core Research Laboratory, ISPRO, Florence, Italy.<br /><searchLink fieldCode="AU" term="%22I+Vokes+N%22">I Vokes N</searchLink>; Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Dietzen+M%22">Dietzen M</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Angelova+M%22">Angelova M</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Gini+B%22">Gini B</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tamaki+W%22">Tamaki W</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Allegakoen+P%22">Allegakoen P</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Wu+W%22">Wu W</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Humpton+TJ%22">Humpton TJ</searchLink>; p53 and Metabolism Laboratory, The Francis Crick Institute, London, UK.; CRUK Beatson Institute, Glasgow, UK.; Glasgow Caledonian University, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Hill+W%22">Hill W</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Tomaschko+M%22">Tomaschko M</searchLink>; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Lu+WT%22">Lu WT</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Haderk+F%22">Haderk F</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Al+Bakir+M%22">Al Bakir M</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Nagano+A%22">Nagano A</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Gimeno-Valiente+F%22">Gimeno-Valiente F</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22de+Carné+Trécesson+S%22">de Carné Trécesson S</searchLink>; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Vendramin+R%22">Vendramin R</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Barbè+V%22">Barbè V</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Mugabo+M%22">Mugabo M</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Weeden+CE%22">Weeden CE</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Rowan+A%22">Rowan A</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22McCoach+CE%22">McCoach CE</searchLink>; Genentech Inc, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Almeida+B%22">Almeida B</searchLink>; The Roger Williams Institute of Hepatology, Foundation for Liver Research, London, UK.; Faculty of Life Sciences & Medicine, King's College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Green+M%22">Green M</searchLink>; Experimental Histopathology, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Gomez+C%22">Gomez C</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Nanjo+S%22">Nanjo S</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Barbosa+D%22">Barbosa D</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Moore+C%22">Moore C</searchLink>; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Przewrocka+J%22">Przewrocka J</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Black+JRM%22">Black JRM</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Grönroos+E%22">Grönroos E</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Suarez-Bonnet+A%22">Suarez-Bonnet A</searchLink>; Experimental Histopathology, The Francis Crick Institute, London, UK.; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK.<br /><searchLink fieldCode="AU" term="%22Priestnall+SL%22">Priestnall SL</searchLink>; Experimental Histopathology, The Francis Crick Institute, London, UK.; Department of Pathobiology & Population Sciences, The Royal Veterinary College, London, UK.<br /><searchLink fieldCode="AU" term="%22Zverev+C%22">Zverev C</searchLink>; Biological Research Facility, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Lighterness+S%22">Lighterness S</searchLink>; Biological Research Facility, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Cormack+J%22">Cormack J</searchLink>; Biological Research Facility, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Olivas+V%22">Olivas V</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Cech+L%22">Cech L</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Andrews+T%22">Andrews T</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rule+B%22">Rule B</searchLink>; Cursorless, London, UK.<br /><searchLink fieldCode="AU" term="%22Jiao+Y%22">Jiao Y</searchLink>; Novogene Europe, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Zhang+X%22">Zhang X</searchLink>; Novogene Europe, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ashford+P%22">Ashford P</searchLink>; Institute of Structural and Molecular Biology, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Durfee+C%22">Durfee C</searchLink>; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Venkatesan+S%22">Venkatesan S</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Temiz+NA%22">Temiz NA</searchLink>; Institute for Health Informatics, University of Minnesota, Minneapolis, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Tan+L%22">Tan L</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Larson+LK%22">Larson LK</searchLink>; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Argyris+PP%22">Argyris PP</searchLink>; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.; School of Dentistry, University of Minnesota, Minneapolis, MN, USA.; College of Dentistry, Ohio State University, Columbus, OH, USA.<br /><searchLink fieldCode="AU" term="%22Brown+WL%22">Brown WL</searchLink>; Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Yu+EA%22">Yu EA</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.; Sutter Health Palo Alto Medical Foundation, Department of Pulmonary and Critical Care, Mountain View, CA, USA.<br /><searchLink fieldCode="AU" term="%22Rotow+JK%22">Rotow JK</searchLink>; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Guha+U%22">Guha U</searchLink>; Thoracic and GI Malignancies Branch, NCI, NIH, Bethesda, MD, USA.; NextCure Inc., Beltsville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Roper+N%22">Roper N</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Biomedical Sciences Program, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Vogel+RI%22">Vogel RI</searchLink>; Department of Obstetrics, Gynecology and Women's Health, University of Minnesota, Minneapolis, MN, USA.<br /><searchLink fieldCode="AU" term="%22Thomas+NJ%22">Thomas NJ</searchLink>; Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Marra+A%22">Marra A</searchLink>; Division of Early Drug Development for Innovative Therapy, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Selenica+P%22">Selenica P</searchLink>; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Yu+H%22">Yu H</searchLink>; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Medicine, Weill Cornell College of Medicine, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Bakhoum+SF%22">Bakhoum SF</searchLink>; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Chew+SK%22">Chew SK</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Reis-Filho+JS%22">Reis-Filho JS</searchLink>; Memorial Sloan Kettering Cancer Center, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Jamal-Hanjani+M%22">Jamal-Hanjani M</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Cancer Metastasis Laboratory, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Vousden+KH%22">Vousden KH</searchLink>; p53 and Metabolism Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22McGranahan+N%22">McGranahan N</searchLink>; Cancer Genome Evolution Research Group, University College London, Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Van+Allen+EM%22">Van Allen EM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kanu+N%22">Kanu N</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Harris+RS%22">Harris RS</searchLink>; Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA.; Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA.<br /><searchLink fieldCode="AU" term="%22Downward+J%22">Downward J</searchLink>; Oncogene Biology Laboratory, The Francis Crick Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Bivona+TG%22">Bivona TG</searchLink>; Departments of Medicine and Cellular and Molecular Pharmacology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. trever.bivona@ucsf.edu.; Chan Zuckerberg Biohub, San Francisco, CA, USA. trever.bivona@ucsf.edu.<br /><searchLink fieldCode="AU" term="%22Swanton+C%22">Swanton C</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229216904%22">Nature genetics</searchLink> [Nat Genet] 2024 Jan; Vol. 56 (1), pp. 60-73. <i>Date of Electronic Publication: </i>2023 Dec 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Co%22">Nature Pub. Co </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9216904 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-1718 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210614036%22">10614036 </searchLink><i>NLM ISO Abbreviation: </i>Nat Genet <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38049664
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41588-023-01592-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 60
    Titles:
      – TitleFull: The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Caswell DR
      – PersonEntity:
          Name:
            NameFull: Gui P
      – PersonEntity:
          Name:
            NameFull: Mayekar MK
      – PersonEntity:
          Name:
            NameFull: Law EK
      – PersonEntity:
          Name:
            NameFull: Pich O
      – PersonEntity:
          Name:
            NameFull: Bailey C
      – PersonEntity:
          Name:
            NameFull: Boumelha J
      – PersonEntity:
          Name:
            NameFull: Kerr DL
      – PersonEntity:
          Name:
            NameFull: Blakely CM
      – PersonEntity:
          Name:
            NameFull: Manabe T
      – PersonEntity:
          Name:
            NameFull: Martinez-Ruiz C
      – PersonEntity:
          Name:
            NameFull: Bakker B
      – PersonEntity:
          Name:
            NameFull: De Dios Palomino Villcas J
      – PersonEntity:
          Name:
            NameFull: I Vokes N
      – PersonEntity:
          Name:
            NameFull: Dietzen M
      – PersonEntity:
          Name:
            NameFull: Angelova M
      – PersonEntity:
          Name:
            NameFull: Gini B
      – PersonEntity:
          Name:
            NameFull: Tamaki W
      – PersonEntity:
          Name:
            NameFull: Allegakoen P
      – PersonEntity:
          Name:
            NameFull: Wu W
      – PersonEntity:
          Name:
            NameFull: Humpton TJ
      – PersonEntity:
          Name:
            NameFull: Hill W
      – PersonEntity:
          Name:
            NameFull: Tomaschko M
      – PersonEntity:
          Name:
            NameFull: Lu WT
      – PersonEntity:
          Name:
            NameFull: Haderk F
      – PersonEntity:
          Name:
            NameFull: Al Bakir M
      – PersonEntity:
          Name:
            NameFull: Nagano A
      – PersonEntity:
          Name:
            NameFull: Gimeno-Valiente F
      – PersonEntity:
          Name:
            NameFull: de Carné Trécesson S
      – PersonEntity:
          Name:
            NameFull: Vendramin R
      – PersonEntity:
          Name:
            NameFull: Barbè V
      – PersonEntity:
          Name:
            NameFull: Mugabo M
      – PersonEntity:
          Name:
            NameFull: Weeden CE
      – PersonEntity:
          Name:
            NameFull: Rowan A
      – PersonEntity:
          Name:
            NameFull: McCoach CE
      – PersonEntity:
          Name:
            NameFull: Almeida B
      – PersonEntity:
          Name:
            NameFull: Green M
      – PersonEntity:
          Name:
            NameFull: Gomez C
      – PersonEntity:
          Name:
            NameFull: Nanjo S
      – PersonEntity:
          Name:
            NameFull: Barbosa D
      – PersonEntity:
          Name:
            NameFull: Moore C
      – PersonEntity:
          Name:
            NameFull: Przewrocka J
      – PersonEntity:
          Name:
            NameFull: Black JRM
      – PersonEntity:
          Name:
            NameFull: Grönroos E
      – PersonEntity:
          Name:
            NameFull: Suarez-Bonnet A
      – PersonEntity:
          Name:
            NameFull: Priestnall SL
      – PersonEntity:
          Name:
            NameFull: Zverev C
      – PersonEntity:
          Name:
            NameFull: Lighterness S
      – PersonEntity:
          Name:
            NameFull: Cormack J
      – PersonEntity:
          Name:
            NameFull: Olivas V
      – PersonEntity:
          Name:
            NameFull: Cech L
      – PersonEntity:
          Name:
            NameFull: Andrews T
      – PersonEntity:
          Name:
            NameFull: Rule B
      – PersonEntity:
          Name:
            NameFull: Jiao Y
      – PersonEntity:
          Name:
            NameFull: Zhang X
      – PersonEntity:
          Name:
            NameFull: Ashford P
      – PersonEntity:
          Name:
            NameFull: Durfee C
      – PersonEntity:
          Name:
            NameFull: Venkatesan S
      – PersonEntity:
          Name:
            NameFull: Temiz NA
      – PersonEntity:
          Name:
            NameFull: Tan L
      – PersonEntity:
          Name:
            NameFull: Larson LK
      – PersonEntity:
          Name:
            NameFull: Argyris PP
      – PersonEntity:
          Name:
            NameFull: Brown WL
      – PersonEntity:
          Name:
            NameFull: Yu EA
      – PersonEntity:
          Name:
            NameFull: Rotow JK
      – PersonEntity:
          Name:
            NameFull: Guha U
      – PersonEntity:
          Name:
            NameFull: Roper N
      – PersonEntity:
          Name:
            NameFull: Yu J
      – PersonEntity:
          Name:
            NameFull: Vogel RI
      – PersonEntity:
          Name:
            NameFull: Thomas NJ
      – PersonEntity:
          Name:
            NameFull: Marra A
      – PersonEntity:
          Name:
            NameFull: Selenica P
      – PersonEntity:
          Name:
            NameFull: Yu H
      – PersonEntity:
          Name:
            NameFull: Bakhoum SF
      – PersonEntity:
          Name:
            NameFull: Chew SK
      – PersonEntity:
          Name:
            NameFull: Reis-Filho JS
      – PersonEntity:
          Name:
            NameFull: Jamal-Hanjani M
      – PersonEntity:
          Name:
            NameFull: Vousden KH
      – PersonEntity:
          Name:
            NameFull: McGranahan N
      – PersonEntity:
          Name:
            NameFull: Van Allen EM
      – PersonEntity:
          Name:
            NameFull: Kanu N
      – PersonEntity:
          Name:
            NameFull: Harris RS
      – PersonEntity:
          Name:
            NameFull: Downward J
      – PersonEntity:
          Name:
            NameFull: Bivona TG
      – PersonEntity:
          Name:
            NameFull: Swanton C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2024 Jan
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1546-1718
          Numbering:
            – Type: volume
              Value: 56
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature genetics
              Type: main
ResultId 1